April 5, 2022
April 5, 2022
As of the latest update by the Greek authorities, the total number of confirmed Covid-19 diagnosed cases in Greece 3,096,135. 62 new deaths were reported raising the total number to 27,746. The number of patients treated in intensive care units is currently 365. 18,425 new cases were announced yesterday in Greece. 6,786 of the new cases were found in the Attica region and 1,652 new cases in the Thessaloniki region.
Greek health authorities announced 18,425 new cases of Covid-19 and 62 virus-related deaths on Monday. The jump in cases from Sunday’s 10,358 was expected as there is significantly less testing on the weekend. The National Organization for Public Health (EODY) also stated that there are currently 365 intubated patients being treated in Intensive Care Units.
The positive cases were identified from a total of 99,351 tests, a positivity rate of 18.55%.
Attica, Greece’s most populous region, remains the epicenter of the pandemic accounting for almost a third of new cases with 6,786. The northern port city of Thessaloniki reported 1,652.
The new cases of Covid-19 bring the total number of reported cases in Greece since the start of the pandemic to 3,096,135, resulting in a total of 27,746 virus-related deaths over the same period.
Unvaccinated health care workers will remain suspended from their jobs “for as long as the pandemic lasts,” the health minister said on Monday.
In response to a parliamentary question, Thanos Plevris said the suspension of the workers in question was “entirely their choice”. Health professionals who do not believe in vaccines “do not believe in their own science,” he added.
In September 2021, the Health Ministry suspended some 5,500 health workers and other personnel at public hospitals have been suspended while telling another 1,000 told they could no longer work at primary healthcare centers.
In yet another twist to the debate over how best to protect children against the coronavirus, researchers reported Wednesday that COVID vaccines conferred diminished protection against hospitalization among children 12 and older during the latest omicron surge.
Vaccine effectiveness against hospitalization held steady in children ages 5 to 11 years, however, and among adolescents ages 12 to 18 years, two doses of the vaccine remained highly protective against critical illness requiring life support.
But effectiveness against hospitalization for less severe illness dropped to just 20% among these children. The findings were published in The New England Journal of Medicine.
The data are broadly consistent with studies showing that, across all age groups, the vaccines lost much of their power against infection with the omicron variant but still prevented severe illness and death.
While any hospitalization is unnerving, it is reassuring that the vaccines still protected children from the worst outcomes of infection, said Dr. Manish Patel, a researcher at the Centers for Disease Control and Prevention who led the study.
Among adolescents in the study who were critically ill, 93% were unvaccinated, and most had at least one underlying condition, Patel noted. “I think the big take-home message is that with the simple act of vaccination, you can prevent most critical illness in most children,” he said.
As of March 23, only about 1 in 4 children ages 5-11, and just over half of adolescents 12-17, were fully vaccinated in the United States. Those percentages have barely budged in the past few months.
For some parents still debating vaccination, the decision is complicated by the seeming retreat of the coronavirus. Cases and deaths have fallen to their lowest levels in a year, and no one yet knows whether the BA.2 subvariant of omicron will bring another wave.
Some parents, believing their children’s risk of COVID to be trivial, have been reluctant to vaccinate them from the start. But while children remain much less likely than adults to become seriously ill, many more of them were hospitalized during the omicron surge than at any other time in the pandemic.
In the new study, the researchers analyzed medical records and interviewed parents of children ages 5 and older who were hospitalized for COVID. They excluded children who tested positive for the coronavirus but had been admitted to the hospital for other reasons.
Because relatively few children are hospitalized for COVID, the researchers were able to identify only 1,185 children, comparing them with 1,627 others who did not have COVID. Among those hospitalized for COVID, 291 received life support and 14 died.
The study included data from 31 hospitals in 23 states, and spanned July 1 to Dec. 18, 2021, when the delta variant was circulating, and Dec. 19 to Feb. 17, when the omicron variant was dominant. During the delta period, effectiveness against hospitalization was more than 90% among the adolescents up to 44 weeks after immunization.
During the omicron surge, however, those numbers dropped sharply to about 40% for protection against hospitalization overall, regardless of the time since vaccination.
When the researchers parsed the data by severity of illness, they found that vaccine effectiveness against critical illness among hospitalized adolescents remained high, at 79%, but had fallen to 20% for less severe illness.
The new study is among the first to look at vaccine effectiveness in relation to severity of illness among hospitalized patients. It’s possible that this trend would appear among adult patients, too, if they were analyzed similarly, said Eli Rosenberg, deputy director for science at the New York state Department of Health.
“This split along critical, noncritical is interesting,” he said. “This definitely adds a new layer.”
In children ages 5 to 11 years, full vaccination had an effectiveness of 68% against hospitalization overall. Those data were gathered during the omicron surge, because these children became eligible for vaccination only on Nov. 2. There were too few to analyze effectiveness by severity of illness.
About 78% of all hospitalized adolescents in the study, and 82% of younger children, had one or more underlying medical conditions, like obesity, autoimmune diseases or respiratory problems, including asthma.
The study suggests that the vaccine protected a majority of these children from the worst outcomes, said Dr. Luciana Borio, a former acting chief scientist at the Food and Drug Administration.
“It really validates the importance of vaccines for children 5 and older, and especially for those that are immunocompromised or have underlying medical conditions,” she said.
In more detail, the 18,425 new cases detected per Regional Unit: